» Authors » Manuela Marron

Manuela Marron

Explore the profile of Manuela Marron including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 538
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Floegel A, Russo P, Veidebaum T, Tornaritis M, Molnar D, Lissner L, et al.
PLoS One . 2025 Feb; 20(2):e0311180. PMID: 39899498
Purpose: Understanding factors influencing clinical biomarkers is important for the prevention of chronic disease. This study aimed to estimate transitions of biomarker status from childhood to adolescence and to identify...
2.
Wolters M, Foraita R, Moreno L, Molnar D, Russo P, Tornaritis M, et al.
Eur J Nutr . 2024 Sep; 63(8):3047-3060. PMID: 39231874
Purpose: To investigate longitudinal associations between the vitamin D status and inflammatory markers in children and adolescents. Methods: Children from eight European countries from the IDEFICS/I.Family cohort with repeated measurements...
3.
Wolters M, Marron M, Foraita R, Hadjigeorgiou C, de Henauw S, Eiben G, et al.
J Clin Endocrinol Metab . 2023 Jun; 108(12):e1731-e1742. PMID: 37261399
Context: Vitamin D status has previously been associated with cardiometabolic risk markers in children and adolescents. In particular, it has been suggested that children with obesity are more prone to...
4.
Grandt C, Brackmann L, Poplawski A, Schwarz H, Marini F, Hankeln T, et al.
Front Oncol . 2023 May; 13:1158176. PMID: 37182169
Introduction: Long non-coding ribonucleic acids (lncRNAs) are involved in the cellular damage response following exposure to ionizing radiation as applied in radiotherapy. However, the role of lncRNAs in radiation response...
5.
Brackmann L, Foraita R, Schwarz H, Poplawski A, Hankeln T, Galetzka D, et al.
Front Oncol . 2023 May; 13:1150629. PMID: 37124517
Background: Childhood cancer survivors (CCS) are at particularly high risk for therapy-related late sequelae, with secondary primary neoplasms (SPN) being the most detrimental. Since there is no standardized questionnaire for...
6.
Grandt C, Brackmann L, Foraita R, Schwarz H, Hummel-Bartenschlager W, Hankeln T, et al.
Mol Med . 2023 Mar; 29(1):41. PMID: 36997855
Background: Differential expression analysis is usually adjusted for variation. However, most studies that examined the expression variability (EV) have used computations affected by low expression levels and did not examine...
7.
Zahnreich S, Yusifli K, Poplawski A, Eckhard L, Mirsch J, Hankeln T, et al.
DNA Repair (Amst) . 2022 Dec; 122:103435. PMID: 36549044
New development and optimization of oncologic strategies are steadily increasing the number of long-term cancer survivors being at risk of developing second primary neoplasms (SPNs) as a late consequence of...
8.
Nagrani R, Marron M, Bongaerts E, Nawrot T, Ameloot M, de Hoogh K, et al.
Environ Pollut . 2022 Dec; 317:120773. PMID: 36455765
The effects of exposure to black carbon (BC) on various diseases remains unclear, one reason being potential exposure misclassification following modelling of ambient air pollution levels. Urinary BC particles may...
9.
Brackmann L, Foraita R, Schwarz H, Galetzka D, Zahnreich S, Hankeln T, et al.
Front Oncol . 2022 Nov; 12:1037276. PMID: 36324589
Background: Improved treatments for childhood cancer result in a growing number of long-term childhood cancer survivors (CCS). The diagnosis and the prevalence of comorbidities may, however, influence their lifestyle later...
10.
Grandt C, Brackmann L, Poplawski A, Schwarz H, Hummel-Bartenschlager W, Hankeln T, et al.
Mol Med . 2022 Sep; 28(1):105. PMID: 36068491
Background: The etiology and most risk factors for a sporadic first primary neoplasm in childhood or subsequent second primary neoplasms are still unknown. One established causal factor for therapy-associated second...